tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

MLTX Stock Latest News

MoonLake Immunotherapeutics: Strategic Positioning and Promising Clinical Developments Drive Buy Rating
RatingsMoonLake Immunotherapeutics: Strategic Positioning and Promising Clinical Developments Drive Buy Rating
1M ago
MLTX
Stat’s Feuerstein says ‘no imminent acquisition’ of MoonLake Immunotherapeutics
PremiumThe Fly
Stat’s Feuerstein says ‘no imminent acquisition’ of MoonLake Immunotherapeutics
1M ago
MRK
MLTX
MoonLake Immunotherapeutics Elects Directors at AGM
PremiumCompany Announcements
MoonLake Immunotherapeutics Elects Directors at AGM
1M ago
8K
MLTX
MoonLake Immunotherapeutics: Strong Acquisition Interest and Promising Product Pipeline Drive Buy Rating
PremiumRatings
MoonLake Immunotherapeutics: Strong Acquisition Interest and Promising Product Pipeline Drive Buy Rating
1M ago
MLTX
MoonLake takeover thesis reemerges after FT report, says Citi
PremiumThe Fly
MoonLake takeover thesis reemerges after FT report, says Citi
1M ago
MRK
MLTX
Closing Bell Movers: Credo Technology jumps 11% on earnings
PremiumThe FlyClosing Bell Movers: Credo Technology jumps 11% on earnings
1M ago
MRK
NUE
Merck held talks to buy MoonLake for over $3B, FT reports
Premium
The Fly
Merck held talks to buy MoonLake for over $3B, FT reports
1M ago
MRK
MLTX
MoonLake Immunotherapeutics: Promising Clinical Developments and Strong Financial Position Justify Buy Rating
Premium
Ratings
MoonLake Immunotherapeutics: Promising Clinical Developments and Strong Financial Position Justify Buy Rating
2M ago
MLTX
Wolfe upgrades MoonLake Immunotherapeutics ahead of sonelokimab data
PremiumThe Fly
Wolfe upgrades MoonLake Immunotherapeutics ahead of sonelokimab data
2M ago
MLTX
MoonLake upgraded to Outperform from Peer Perform at Wolfe Research
PremiumThe Fly
MoonLake upgraded to Outperform from Peer Perform at Wolfe Research
2M ago
MLTX
MoonLake Immunotherapeutics: Buy Rating Driven by Strategic Developments and Promising Clinical Programs
PremiumRatings
MoonLake Immunotherapeutics: Buy Rating Driven by Strategic Developments and Promising Clinical Programs
2M ago
MLTX
MoonLake Immunotherapeutics: Strong Financials and Promising Pipeline Drive Buy Rating
PremiumRatings
MoonLake Immunotherapeutics: Strong Financials and Promising Pipeline Drive Buy Rating
2M ago
MLTX
MoonLake Immunotherapeutics: Strong Financial Position and Promising Data Releases Justify Buy Rating
PremiumRatingsMoonLake Immunotherapeutics: Strong Financial Position and Promising Data Releases Justify Buy Rating
2M ago
MLTX
Promising Growth Potential and Financial Strength Drive Buy Rating for MoonLake Immunotherapeutics
Premium
Ratings
Promising Growth Potential and Financial Strength Drive Buy Rating for MoonLake Immunotherapeutics
2M ago
MLTX
MoonLake Immunotherapeutics: Promising Clinical Developments and Market Opportunities Justify Buy Rating
Premium
Ratings
MoonLake Immunotherapeutics: Promising Clinical Developments and Market Opportunities Justify Buy Rating
2M ago
MLTX
MoonLake Immunotherapeutics reports Q1 EPS (63c), consensus (74c)
PremiumThe Fly
MoonLake Immunotherapeutics reports Q1 EPS (63c), consensus (74c)
2M ago
MLTX
MoonLake Immunotherapeutics: Promising Clinical Updates and Market Potential Support Buy Rating
PremiumRatings
MoonLake Immunotherapeutics: Promising Clinical Updates and Market Potential Support Buy Rating
2M ago
MLTX
MoonLake Immunotherapeutics price target raised to $85 from $81 at BTIG
PremiumThe Fly
MoonLake Immunotherapeutics price target raised to $85 from $81 at BTIG
3M ago
MLTX
MoonLake Immunotherapeutics: Promising Developments and Financial Strength Justify Buy Rating
PremiumRatings
MoonLake Immunotherapeutics: Promising Developments and Financial Strength Justify Buy Rating
3M ago
MLTX
MoonLake Immunotherapeutics: Promising Developments and Strategic Positioning Justify Buy Rating
PremiumRatingsMoonLake Immunotherapeutics: Promising Developments and Strategic Positioning Justify Buy Rating
3M ago
MLTX
MoonLake Immunotherapeutics: Promising Clinical Trials and Market Potential Drive Buy Rating
Premium
Ratings
MoonLake Immunotherapeutics: Promising Clinical Trials and Market Potential Drive Buy Rating
3M ago
MLTX
MoonLake Immunotherapeutics Hosts Capital Markets Day
Premium
Company Announcements
MoonLake Immunotherapeutics Hosts Capital Markets Day
3M ago
8K
MLTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >